Lipid-lowering therapies for cardiovascular disease prevention and management in primary care
Date Added:
October 15, 2023
Journal/Publication:
CFP
Publisher:
College of Family Physicians of Canada
Publication Date:
October 1, 2023
Issue:
10
Volume:
69
Pages:
701-711
Type:
Meta-analyses, Reviews, and Guidelines
Format:
Article
DOI (1):
10.46747/cfp.6910701
PMID (1):
37833094
Abstract
Objective: To assess the benefits and harms of lipid-lowering therapies used to prevent or manage cardiovascular disease including bile acid sequestrants (BAS), ezetimibe, fibrates, niacin, omega-3 supplements, proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, and statins.
Text Availability
Free full text
RPR Commentary
An analysis of the evidence of the impact of various lipid lowering strategies in cardiovascular events and mortality. James W. Mold, MD, MPH